Pàgina inicial > Resultats de la cerca: Bower, Mark
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 2 registres trobats en 0.01 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
9 p, 203.7 KB Outcomes of men with HIV and germ cell cancer : Results from an international collaborative study / Hentrich, Marcus Ulrich (Department of Hematology and Oncology. Red Cross Hospital. University of Munich) ; Bower, Mark (National Centre for HIV Malignancy. Chelsea and Westminster Hospital) ; Daugaard, Gedske (Department of Oncology. University Hospital Copenhagen. Rigshospitalet) ; Dieing, Annette (Department of Hematology and Oncology. Vivantes Klinikum am Urban) ; Bickel, Markus (Infektiologikum) ; Berretta, Massimiliano (Department of Clinical and Experimental Medicine. University of Messina) ; Lesmeister, Florian (Department of Hematology and Oncology. Red Cross Hospital. University of Munich) ; Jurinovic, Vindi (Institute of Biometrics and Epidemiology. Ludwig Maximilian University of Munich) ; Stoehr, Albrecht (Institute for Interdisciplinary Medicine) ; Heinzelbecker, Julia (Department of Urology and Pediatric Urology. Saarland University Medical Center and Saarland University) ; Krznaric, Ivanka (Practice of Infectious Diseases) ; Dieckmann, Klaus-Peter (Department of Urology. Asklepios Klinik Altona) ; Necchi, Andrea (IRCCS San Raffaele Hospital and Scientific Institute. Vita-Salute San Raffaele University) ; Maroto Rey, Pablo (Institut d'Investigació Biomèdica Sant Pau) ; Rockstroh, Jürgen Kurt (Department of Medicine I. University Hospital Bonn) ; Brito, Margarida (Instituto Português de Oncologia Francisco Gentil) ; Pfister, David (Department of Urology. University Hospital Cologne) ; Hoffmann, Christian (University Hospital of Schleswig Holstein)
Background: Previous studies have shown that men with HIV and germ cell cancer (HIV-GCC) have inferior overall survival (OS) in comparison with their HIV-negative counterparts. However, little information is available on treatments and outcomes of HIV-GCC in the era of combination antiretroviral therapy (cART). [...]
2022 - 10.1002/cncr.33928
Cancer, Vol. 128 Núm. 2 (January 2022) , p. 260-268  
Registre complet - Creative Commons
2.
14 p, 502.9 KB Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe / Pinato, David J. (Imperial College London. Department of Surgery & Cancer) ; Lee, Alvin J. X. (University College London Hospitals) ; Biello, Federica (University of Piemonte Orientale) ; Seguí, Elia (Hospital Clínic i Provincial de Barcelona) ; Aguilar-Company, Juan (Hospital Universitari Vall d'Hebron) ; Carbó, Anna (Hospital Universitari de Girona Doctor Josep Trueta) ; Bruna, Riccardo (University of Piemonte Orientale) ; Bower, Mark (Chelsea & Westminster Hospital) ; Rizzo, Gianpiero (Fondazione IRCCS Policlinico San Matteo) ; Benafif, Sarah (University College London Hospitals) ; Carmona, Carme (Hospital Universitari de Girona Doctor Josep Trueta) ; Chopra, Neha (University College London Hospitals) ; Cruz, Claudia Andrea (Hospital Clínic i Provincial de Barcelona) ; D'avanzo, Francesca (University of Piemonte Orientale) ; Evans, Joanne S. (Imperial College London) ; Galazi, Myria (University College London Hospitals) ; Garcia-Fructuoso, Isabel (Hospital Universitari de Girona Doctor Josep Trueta) ; Pria, Alessia D. (Chelsea & Westminster Hospital) ; Newsom-Davis, Thomas (Chelsea & Westminster Hospital) ; Ottaviani, Diego (University College London Hospitals) ; Patriarca, Andrea (University of Piemonte Orientale) ; Reyes, Roxana (Hospital Clínic i Provincial de Barcelona) ; Sharkey, Rachel (University of Piemonte Orientale) ; Sng, Christopher C. T. (University College London Hospitals) ; Wong, Yien Ning Sophia (University College London Hospitals) ; Ferrante, Daniela (University of Piemonte Orientale) ; Scotti, Lorenza (University of Piemonte Orientale) ; Avanzi, Gian Carlo (University of Piemonte Orientale) ; Bellan, Mattia (University of Piemonte Orientale) ; Castello, Luigi Mario (University of Piemonte Orientale) ; Marco-Hernández, Javier (Hospital Clínic i Provincial de Barcelona) ; Mollà, Meritxell (Hospital Clínic i Provincial de Barcelona) ; Pirisi, Mario (University of Piemonte Orientale) ; Ruiz-Camps, Isabel (Hospital Universitari Vall d'Hebron) ; Sainaghi, Pier Paolo (University of Piemonte Orientale) ; Gaidano, Gianluca (University of Piemonte Orientale) ; Brunet, Joan (Hospital Universitari de Girona Doctor Josep Trueta) ; Tabernero, Josep (Vall d'Hebron Institut d'Oncologia) ; Prat, Aleix (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Gennari, Alessandra (University of Piemonte Orientale) ; Universitat Autònoma de Barcelona
We describe the outcomes in cancer patients during the initial outbreak of the COVID-19 in Europe from the retrospective, multi-center observational OnCovid study. We identified 204 cancer patients from eight centers in the United Kingdom, Italy, and Spain aged > 18 (mean = 69) and diagnosed with COVID-19 between February 26th and April 1st, 2020. [...]
2020 - 10.3390/cancers12071841
Cancers, Vol. 12 Núm. 7 (july 2020) , p. 1-13  
Registre complet - Creative Commons

Vegeu també: autors amb noms similars
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem